SUZUKI, Yoshiyuki; MIMURA, Kousaku; YOSHIMOTO, Yuya. Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma. Cancer Research, 2012-08-15, roč. 72, čís. 16, s. 3967–3976. PMID: 22700877. Dostupné online [cit. 2018-01-14]. ISSN0008-5472. DOI: 10.1158/0008-5472.CAN-12-0851. (po anglicky)
KORBELIK, Mladen; SUN, Jinghai; CECIC, Ivana. Photodynamic Therapy–Induced Cell Surface Expression and Release of Heat Shock Proteins: Relevance for Tumor Response. Cancer Research, 2005-02-01, roč. 65, čís. 3, s. 1018–1026. PMID: 15705903. Dostupné online [cit. 2018-01-14]. ISSN0008-5472. (po anglicky)
mct.aacrjournals.org
HAN, Weidong; LI, Ling; QIU, Shuang. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Molecular Cancer Therapeutics, 2007-05-01, roč. 6, čís. 5, s. 1641–1649. PMID: 17513612. Dostupné online [cit. 2018-01-14]. ISSN1535-7163. DOI: 10.1158/1535-7163.MCT-06-0511. (po anglicky)
cancerimmunolres.aacrjournals.org
CHIOCCA, E. Antonio; RABKIN, Samuel D.. Oncolytic Viruses and Their Application to Cancer Immunotherapy. Cancer Immunology Research, 2014-04-01, roč. 2, čís. 4, s. 295–300. PMID: 24764576. Dostupné online [cit. 2018-01-14]. ISSN2326-6066. DOI: 10.1158/2326-6066.CIR-14-0015. (po anglicky)
cancer.gov
Photodynamic Therapy for Cancer [online]. National Cancer Institute, [cit. 2018-01-14]. Dostupné online. (po anglicky)
doi.org
dx.doi.org
TESNIERE, A; PANARETAKIS, T; KEPP, O. Molecular characteristics of immunogenic cancer cell death. Cell Death & Differentiation, 2008/01, roč. 15, čís. 1, s. 3–12. Dostupné online [cit. 2018-01-14]. ISSN1476-5403. DOI: 10.1038/sj.cdd.4402269. (En)
TANG, Daolin; KANG, Rui; COYNE, Carolyn B.. PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity. Immunological reviews, 2012-9, roč. 249, čís. 1, s. 158–175. PMID: 22889221
PMCID: PMC3662247. Dostupné online [cit. 2018-01-14]. ISSN0105-2896. DOI: 10.1111/j.1600-065X.2012.01146.x.
GARG, A D; MARTIN, S; GOLAB, J. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death and Differentiation, 2014-01, roč. 21, čís. 1, s. 26–38. PMID: 23686135
PMCID: PMC3858605. Dostupné online [cit. 2018-01-14]. ISSN1350-9047. DOI: 10.1038/cdd.2013.48.
KROEMER, Guido; GALLUZZI, Lorenzo; KEPP, Oliver. Immunogenic Cell Death in Cancer Therapy. Annual Review of Immunology, 2013, roč. 31, čís. 1, s. 51–72. PMID: 23157435. Dostupné online [cit. 2018-01-14]. DOI: 10.1146/annurev-immunol-032712-100008.
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology, 2007-10-01, roč. 28, čís. 10, s. 429–436. Dostupné online [cit. 2018-01-14]. ISSN1471-4906. DOI: 10.1016/j.it.2007.08.004.
GARG, Abhishek D.; GALLUZZI, Lorenzo; APETOH, Lionel. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology, 2015-11-20, roč. 6. PMID: 26635802
PMCID: PMC4653610. Dostupné online [cit. 2018-01-14]. ISSN1664-3224. DOI: 10.3389/fimmu.2015.00588.
Calreticulin is an upstream regulator of calcineurin. Biochemical and Biophysical Research Communications, 2003-11-28, roč. 311, čís. 4, s. 1173–1179. Dostupné online [cit. 2018-01-14]. ISSN0006-291X. DOI: 10.1016/j.bbrc.2003.08.040.
Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Oral Oncology, 2013-06-01, roč. 49, čís. 6, s. 534–541. Dostupné online [cit. 2018-01-14]. ISSN1368-8375. DOI: 10.1016/j.oraloncology.2013.01.003.
OBEID, M; PANARETAKIS, T; JOZA, N. Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis. Cell Death & Differentiation, 2007/10, roč. 14, čís. 10, s. 1848–1850. Dostupné online [cit. 2018-01-14]. ISSN1476-5403. DOI: 10.1038/sj.cdd.4402201. (En)
LANNEAU, D; BRUNET, M; FRISAN, E. Heat shock proteins: essential proteins for apoptosis regulation. Journal of Cellular and Molecular Medicine, 2008-6, roč. 12, čís. 3, s. 743–761. PMID: 18266962
PMCID: PMC4401125. Dostupné online [cit. 2018-01-14]. ISSN1582-1838. DOI: 10.1111/j.1582-4934.2008.00273.x.
APETOH, Lionel; GHIRINGHELLI, François; TESNIERE, Antoine. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunological Reviews, 2007-12-01, roč. 220, čís. 1, s. 47–59. Dostupné online [cit. 2018-01-14]. ISSN1600-065X. DOI: 10.1111/j.1600-065X.2007.00573.x. (po anglicky)
HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expression Patterns, 2003-03-01, roč. 3, čís. 1, s. 29–33. Dostupné online [cit. 2018-01-14]. ISSN1567-133X. DOI: 10.1016/S1567-133X(02)00093-5.
CASEY, Stephanie C.; LI, Yulin; FELSHER, Dean W.. An Essential Role for the Immune System in the Mechanism of Tumor Regression Following Targeted Oncogene Inactivation. Immunologic research, 2014-5, roč. 58, čís. 0, s. 282–291. PMID: 24791942
PMCID: PMC4201505. Dostupné online [cit. 2018-01-14]. ISSN0257-277X. DOI: 10.1007/s12026-014-8503-6.
BEZU, Lucillia; GOMES-DA-SILVA, Ligia C.; DEWITTE, Heleen. Combinatorial Strategies for the Induction of Immunogenic Cell Death. Frontiers in Immunology, 2015, roč. 6. Dostupné online [cit. 2018-01-14]. ISSN1664-3224. DOI: 10.3389/fimmu.2015.00187. (English)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. International Journal of Radiation Oncology*Biology*Physics, 2004-03-01, roč. 58, čís. 3, s. 862–870. Dostupné online [cit. 2018-01-14]. ISSN0360-3016. DOI: 10.1016/j.ijrobp.2003.09.012.
SUZUKI, Yoshiyuki; MIMURA, Kousaku; YOSHIMOTO, Yuya. Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma. Cancer Research, 2012-08-15, roč. 72, čís. 16, s. 3967–3976. PMID: 22700877. Dostupné online [cit. 2018-01-14]. ISSN0008-5472. DOI: 10.1158/0008-5472.CAN-12-0851. (po anglicky)
HAN, Weidong; LI, Ling; QIU, Shuang. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Molecular Cancer Therapeutics, 2007-05-01, roč. 6, čís. 5, s. 1641–1649. PMID: 17513612. Dostupné online [cit. 2018-01-14]. ISSN1535-7163. DOI: 10.1158/1535-7163.MCT-06-0511. (po anglicky)
CHEN, Ching-Hsein; CHERN, Chi-Liang; LIN, Chun-Ching. Involvement of Reactive Oxygen Species, but not Mitochondrial Permeability Transition in the Apoptotic Induction of Human SK-Hep-1 Hepatoma Cells by Shikonin. Planta Medica, 2003/12, roč. 69, čís. 12, s. 1119–1124. Dostupné online [cit. 2018-01-14]. ISSN0032-0943. DOI: 10.1055/s-2003-45193. (po nemecky)
YANG, Huanjie; ZHOU, Ping; HUANG, Hongbiao. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. International Journal of Cancer, 2009-05-15, roč. 124, čís. 10, s. 2450–2459. Dostupné online [cit. 2018-01-14]. ISSN1097-0215. DOI: 10.1002/ijc.24195. (po anglicky)
CHEN, Hui-Ming; WANG, Pi-Hsueh; CHEN, Swey-Shen. Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunology, Immunotherapy, 2012-11-01, roč. 61, čís. 11, s. 1989–2002. Dostupné online [cit. 2018-01-14]. ISSN0340-7004. DOI: 10.1007/s00262-012-1258-9. (po anglicky)
LAWLER, Sean E.; SPERANZA, Maria-Carmela; CHO, Choi-Fong. Oncolytic Viruses in Cancer Treatment. JAMA Oncology, 2017-06-01, roč. 3, čís. 6. Dostupné online [cit. 2018-01-14]. ISSN2374-2437. DOI: 10.1001/jamaoncol.2016.2064. (po anglicky)
GARG, Abhishek D.; KRYSKO, Dmitri V.; VANDENABEELE, Peter. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunology, Immunotherapy, 2012-02-01, roč. 61, čís. 2, s. 215–221. Dostupné online [cit. 2018-01-14]. ISSN0340-7004. DOI: 10.1007/s00262-011-1184-2. (po anglicky)
Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007-09-01, roč. 1776, čís. 1, s. 86–107. Dostupné online [cit. 2018-01-14]. ISSN0304-419X. DOI: 10.1016/j.bbcan.2007.07.001.
PANZARINI, Elisa; INGUSCIO, Valentina; FIMIA, Gian Maria. Rose Bengal Acetate PhotoDynamic Therapy (RBAc-PDT) Induces Exposure and Release of Damage-Associated Molecular Patterns (DAMPs) in Human HeLa Cells. PLoS ONE, 2014-08-20, roč. 9, čís. 8. PMID: 25140900
PMCID: PMC4139382. Dostupné online [cit. 2018-01-14]. ISSN1932-6203. DOI: 10.1371/journal.pone.0105778.
ETMINAN, N; PETERS, C; LAKBIR, D. Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. British Journal of Cancer, 2011-09-27, roč. 105, čís. 7, s. 961–969. PMID: 21863026
PMCID: PMC3185943. Dostupné online [cit. 2018-01-14]. ISSN0007-0920. DOI: 10.1038/bjc.2011.327.
CHIOCCA, E. Antonio; RABKIN, Samuel D.. Oncolytic Viruses and Their Application to Cancer Immunotherapy. Cancer Immunology Research, 2014-04-01, roč. 2, čís. 4, s. 295–300. PMID: 24764576. Dostupné online [cit. 2018-01-14]. ISSN2326-6066. DOI: 10.1158/2326-6066.CIR-14-0015. (po anglicky)
FUKUHARA, Hiroshi; INO, Yasushi; TODO, Tomoki. Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer Science, 2016-10, roč. 107, čís. 10, s. 1373–1379. PMID: 27486853
PMCID: PMC5084676. Dostupné online [cit. 2018-01-14]. ISSN1347-9032. DOI: 10.1111/cas.13027.
doi.org
KROEMER, Guido; GALLUZZI, Lorenzo; KEPP, Oliver. Immunogenic Cell Death in Cancer Therapy. Annual Review of Immunology, 2013, roč. 31, čís. 1, s. 51–72. PMID: 23157435. Dostupné online [cit. 2018-01-14]. DOI: 10.1146/annurev-immunol-032712-100008.
frontiersin.org
BEZU, Lucillia; GOMES-DA-SILVA, Ligia C.; DEWITTE, Heleen. Combinatorial Strategies for the Induction of Immunogenic Cell Death. Frontiers in Immunology, 2015, roč. 6. Dostupné online [cit. 2018-01-14]. ISSN1664-3224. DOI: 10.3389/fimmu.2015.00187. (English)
jamanetwork.com
LAWLER, Sean E.; SPERANZA, Maria-Carmela; CHO, Choi-Fong. Oncolytic Viruses in Cancer Treatment. JAMA Oncology, 2017-06-01, roč. 3, čís. 6. Dostupné online [cit. 2018-01-14]. ISSN2374-2437. DOI: 10.1001/jamaoncol.2016.2064. (po anglicky)
nature.com
TESNIERE, A; PANARETAKIS, T; KEPP, O. Molecular characteristics of immunogenic cancer cell death. Cell Death & Differentiation, 2008/01, roč. 15, čís. 1, s. 3–12. Dostupné online [cit. 2018-01-14]. ISSN1476-5403. DOI: 10.1038/sj.cdd.4402269. (En)
OBEID, M; PANARETAKIS, T; JOZA, N. Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis. Cell Death & Differentiation, 2007/10, roč. 14, čís. 10, s. 1848–1850. Dostupné online [cit. 2018-01-14]. ISSN1476-5403. DOI: 10.1038/sj.cdd.4402201. (En)
nih.gov
ncbi.nlm.nih.gov
TANG, Daolin; KANG, Rui; COYNE, Carolyn B.. PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity. Immunological reviews, 2012-9, roč. 249, čís. 1, s. 158–175. PMID: 22889221
PMCID: PMC3662247. Dostupné online [cit. 2018-01-14]. ISSN0105-2896. DOI: 10.1111/j.1600-065X.2012.01146.x.
GARG, A D; MARTIN, S; GOLAB, J. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death and Differentiation, 2014-01, roč. 21, čís. 1, s. 26–38. PMID: 23686135
PMCID: PMC3858605. Dostupné online [cit. 2018-01-14]. ISSN1350-9047. DOI: 10.1038/cdd.2013.48.
GARG, Abhishek D.; GALLUZZI, Lorenzo; APETOH, Lionel. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology, 2015-11-20, roč. 6. PMID: 26635802
PMCID: PMC4653610. Dostupné online [cit. 2018-01-14]. ISSN1664-3224. DOI: 10.3389/fimmu.2015.00588.
LANNEAU, D; BRUNET, M; FRISAN, E. Heat shock proteins: essential proteins for apoptosis regulation. Journal of Cellular and Molecular Medicine, 2008-6, roč. 12, čís. 3, s. 743–761. PMID: 18266962
PMCID: PMC4401125. Dostupné online [cit. 2018-01-14]. ISSN1582-1838. DOI: 10.1111/j.1582-4934.2008.00273.x.
CASEY, Stephanie C.; LI, Yulin; FELSHER, Dean W.. An Essential Role for the Immune System in the Mechanism of Tumor Regression Following Targeted Oncogene Inactivation. Immunologic research, 2014-5, roč. 58, čís. 0, s. 282–291. PMID: 24791942
PMCID: PMC4201505. Dostupné online [cit. 2018-01-14]. ISSN0257-277X. DOI: 10.1007/s12026-014-8503-6.
PANZARINI, Elisa; INGUSCIO, Valentina; FIMIA, Gian Maria. Rose Bengal Acetate PhotoDynamic Therapy (RBAc-PDT) Induces Exposure and Release of Damage-Associated Molecular Patterns (DAMPs) in Human HeLa Cells. PLoS ONE, 2014-08-20, roč. 9, čís. 8. PMID: 25140900
PMCID: PMC4139382. Dostupné online [cit. 2018-01-14]. ISSN1932-6203. DOI: 10.1371/journal.pone.0105778.
ETMINAN, N; PETERS, C; LAKBIR, D. Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. British Journal of Cancer, 2011-09-27, roč. 105, čís. 7, s. 961–969. PMID: 21863026
PMCID: PMC3185943. Dostupné online [cit. 2018-01-14]. ISSN0007-0920. DOI: 10.1038/bjc.2011.327.
FUKUHARA, Hiroshi; INO, Yasushi; TODO, Tomoki. Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer Science, 2016-10, roč. 107, čís. 10, s. 1373–1379. PMID: 27486853
PMCID: PMC5084676. Dostupné online [cit. 2018-01-14]. ISSN1347-9032. DOI: 10.1111/cas.13027.
sciencedirect.com
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology, 2007-10-01, roč. 28, čís. 10, s. 429–436. Dostupné online [cit. 2018-01-14]. ISSN1471-4906. DOI: 10.1016/j.it.2007.08.004.
Calreticulin is an upstream regulator of calcineurin. Biochemical and Biophysical Research Communications, 2003-11-28, roč. 311, čís. 4, s. 1173–1179. Dostupné online [cit. 2018-01-14]. ISSN0006-291X. DOI: 10.1016/j.bbrc.2003.08.040.
Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Oral Oncology, 2013-06-01, roč. 49, čís. 6, s. 534–541. Dostupné online [cit. 2018-01-14]. ISSN1368-8375. DOI: 10.1016/j.oraloncology.2013.01.003.
HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expression Patterns, 2003-03-01, roč. 3, čís. 1, s. 29–33. Dostupné online [cit. 2018-01-14]. ISSN1567-133X. DOI: 10.1016/S1567-133X(02)00093-5.
Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007-09-01, roč. 1776, čís. 1, s. 86–107. Dostupné online [cit. 2018-01-14]. ISSN0304-419X. DOI: 10.1016/j.bbcan.2007.07.001.
springer.com
link.springer.com
CHEN, Hui-Ming; WANG, Pi-Hsueh; CHEN, Swey-Shen. Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunology, Immunotherapy, 2012-11-01, roč. 61, čís. 11, s. 1989–2002. Dostupné online [cit. 2018-01-14]. ISSN0340-7004. DOI: 10.1007/s00262-012-1258-9. (po anglicky)
GARG, Abhishek D.; KRYSKO, Dmitri V.; VANDENABEELE, Peter. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunology, Immunotherapy, 2012-02-01, roč. 61, čís. 2, s. 215–221. Dostupné online [cit. 2018-01-14]. ISSN0340-7004. DOI: 10.1007/s00262-011-1184-2. (po anglicky)
thieme-connect.com
CHEN, Ching-Hsein; CHERN, Chi-Liang; LIN, Chun-Ching. Involvement of Reactive Oxygen Species, but not Mitochondrial Permeability Transition in the Apoptotic Induction of Human SK-Hep-1 Hepatoma Cells by Shikonin. Planta Medica, 2003/12, roč. 69, čís. 12, s. 1119–1124. Dostupné online [cit. 2018-01-14]. ISSN0032-0943. DOI: 10.1055/s-2003-45193. (po nemecky)
wiley.com
onlinelibrary.wiley.com
APETOH, Lionel; GHIRINGHELLI, François; TESNIERE, Antoine. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunological Reviews, 2007-12-01, roč. 220, čís. 1, s. 47–59. Dostupné online [cit. 2018-01-14]. ISSN1600-065X. DOI: 10.1111/j.1600-065X.2007.00573.x. (po anglicky)
YANG, Huanjie; ZHOU, Ping; HUANG, Hongbiao. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. International Journal of Cancer, 2009-05-15, roč. 124, čís. 10, s. 2450–2459. Dostupné online [cit. 2018-01-14]. ISSN1097-0215. DOI: 10.1002/ijc.24195. (po anglicky)
worldcat.org
TESNIERE, A; PANARETAKIS, T; KEPP, O. Molecular characteristics of immunogenic cancer cell death. Cell Death & Differentiation, 2008/01, roč. 15, čís. 1, s. 3–12. Dostupné online [cit. 2018-01-14]. ISSN1476-5403. DOI: 10.1038/sj.cdd.4402269. (En)
TANG, Daolin; KANG, Rui; COYNE, Carolyn B.. PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity. Immunological reviews, 2012-9, roč. 249, čís. 1, s. 158–175. PMID: 22889221
PMCID: PMC3662247. Dostupné online [cit. 2018-01-14]. ISSN0105-2896. DOI: 10.1111/j.1600-065X.2012.01146.x.
GARG, A D; MARTIN, S; GOLAB, J. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death and Differentiation, 2014-01, roč. 21, čís. 1, s. 26–38. PMID: 23686135
PMCID: PMC3858605. Dostupné online [cit. 2018-01-14]. ISSN1350-9047. DOI: 10.1038/cdd.2013.48.
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology, 2007-10-01, roč. 28, čís. 10, s. 429–436. Dostupné online [cit. 2018-01-14]. ISSN1471-4906. DOI: 10.1016/j.it.2007.08.004.
GARG, Abhishek D.; GALLUZZI, Lorenzo; APETOH, Lionel. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology, 2015-11-20, roč. 6. PMID: 26635802
PMCID: PMC4653610. Dostupné online [cit. 2018-01-14]. ISSN1664-3224. DOI: 10.3389/fimmu.2015.00588.
Calreticulin is an upstream regulator of calcineurin. Biochemical and Biophysical Research Communications, 2003-11-28, roč. 311, čís. 4, s. 1173–1179. Dostupné online [cit. 2018-01-14]. ISSN0006-291X. DOI: 10.1016/j.bbrc.2003.08.040.
Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Oral Oncology, 2013-06-01, roč. 49, čís. 6, s. 534–541. Dostupné online [cit. 2018-01-14]. ISSN1368-8375. DOI: 10.1016/j.oraloncology.2013.01.003.
OBEID, M; PANARETAKIS, T; JOZA, N. Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis. Cell Death & Differentiation, 2007/10, roč. 14, čís. 10, s. 1848–1850. Dostupné online [cit. 2018-01-14]. ISSN1476-5403. DOI: 10.1038/sj.cdd.4402201. (En)
LANNEAU, D; BRUNET, M; FRISAN, E. Heat shock proteins: essential proteins for apoptosis regulation. Journal of Cellular and Molecular Medicine, 2008-6, roč. 12, čís. 3, s. 743–761. PMID: 18266962
PMCID: PMC4401125. Dostupné online [cit. 2018-01-14]. ISSN1582-1838. DOI: 10.1111/j.1582-4934.2008.00273.x.
APETOH, Lionel; GHIRINGHELLI, François; TESNIERE, Antoine. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunological Reviews, 2007-12-01, roč. 220, čís. 1, s. 47–59. Dostupné online [cit. 2018-01-14]. ISSN1600-065X. DOI: 10.1111/j.1600-065X.2007.00573.x. (po anglicky)
HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expression Patterns, 2003-03-01, roč. 3, čís. 1, s. 29–33. Dostupné online [cit. 2018-01-14]. ISSN1567-133X. DOI: 10.1016/S1567-133X(02)00093-5.
CASEY, Stephanie C.; LI, Yulin; FELSHER, Dean W.. An Essential Role for the Immune System in the Mechanism of Tumor Regression Following Targeted Oncogene Inactivation. Immunologic research, 2014-5, roč. 58, čís. 0, s. 282–291. PMID: 24791942
PMCID: PMC4201505. Dostupné online [cit. 2018-01-14]. ISSN0257-277X. DOI: 10.1007/s12026-014-8503-6.
BEZU, Lucillia; GOMES-DA-SILVA, Ligia C.; DEWITTE, Heleen. Combinatorial Strategies for the Induction of Immunogenic Cell Death. Frontiers in Immunology, 2015, roč. 6. Dostupné online [cit. 2018-01-14]. ISSN1664-3224. DOI: 10.3389/fimmu.2015.00187. (English)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. International Journal of Radiation Oncology*Biology*Physics, 2004-03-01, roč. 58, čís. 3, s. 862–870. Dostupné online [cit. 2018-01-14]. ISSN0360-3016. DOI: 10.1016/j.ijrobp.2003.09.012.
SUZUKI, Yoshiyuki; MIMURA, Kousaku; YOSHIMOTO, Yuya. Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma. Cancer Research, 2012-08-15, roč. 72, čís. 16, s. 3967–3976. PMID: 22700877. Dostupné online [cit. 2018-01-14]. ISSN0008-5472. DOI: 10.1158/0008-5472.CAN-12-0851. (po anglicky)
HAN, Weidong; LI, Ling; QIU, Shuang. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Molecular Cancer Therapeutics, 2007-05-01, roč. 6, čís. 5, s. 1641–1649. PMID: 17513612. Dostupné online [cit. 2018-01-14]. ISSN1535-7163. DOI: 10.1158/1535-7163.MCT-06-0511. (po anglicky)
CHEN, Ching-Hsein; CHERN, Chi-Liang; LIN, Chun-Ching. Involvement of Reactive Oxygen Species, but not Mitochondrial Permeability Transition in the Apoptotic Induction of Human SK-Hep-1 Hepatoma Cells by Shikonin. Planta Medica, 2003/12, roč. 69, čís. 12, s. 1119–1124. Dostupné online [cit. 2018-01-14]. ISSN0032-0943. DOI: 10.1055/s-2003-45193. (po nemecky)
YANG, Huanjie; ZHOU, Ping; HUANG, Hongbiao. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. International Journal of Cancer, 2009-05-15, roč. 124, čís. 10, s. 2450–2459. Dostupné online [cit. 2018-01-14]. ISSN1097-0215. DOI: 10.1002/ijc.24195. (po anglicky)
CHEN, Hui-Ming; WANG, Pi-Hsueh; CHEN, Swey-Shen. Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunology, Immunotherapy, 2012-11-01, roč. 61, čís. 11, s. 1989–2002. Dostupné online [cit. 2018-01-14]. ISSN0340-7004. DOI: 10.1007/s00262-012-1258-9. (po anglicky)
LAWLER, Sean E.; SPERANZA, Maria-Carmela; CHO, Choi-Fong. Oncolytic Viruses in Cancer Treatment. JAMA Oncology, 2017-06-01, roč. 3, čís. 6. Dostupné online [cit. 2018-01-14]. ISSN2374-2437. DOI: 10.1001/jamaoncol.2016.2064. (po anglicky)
GARG, Abhishek D.; KRYSKO, Dmitri V.; VANDENABEELE, Peter. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunology, Immunotherapy, 2012-02-01, roč. 61, čís. 2, s. 215–221. Dostupné online [cit. 2018-01-14]. ISSN0340-7004. DOI: 10.1007/s00262-011-1184-2. (po anglicky)
Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007-09-01, roč. 1776, čís. 1, s. 86–107. Dostupné online [cit. 2018-01-14]. ISSN0304-419X. DOI: 10.1016/j.bbcan.2007.07.001.
KORBELIK, Mladen; SUN, Jinghai; CECIC, Ivana. Photodynamic Therapy–Induced Cell Surface Expression and Release of Heat Shock Proteins: Relevance for Tumor Response. Cancer Research, 2005-02-01, roč. 65, čís. 3, s. 1018–1026. PMID: 15705903. Dostupné online [cit. 2018-01-14]. ISSN0008-5472. (po anglicky)
PANZARINI, Elisa; INGUSCIO, Valentina; FIMIA, Gian Maria. Rose Bengal Acetate PhotoDynamic Therapy (RBAc-PDT) Induces Exposure and Release of Damage-Associated Molecular Patterns (DAMPs) in Human HeLa Cells. PLoS ONE, 2014-08-20, roč. 9, čís. 8. PMID: 25140900
PMCID: PMC4139382. Dostupné online [cit. 2018-01-14]. ISSN1932-6203. DOI: 10.1371/journal.pone.0105778.
ETMINAN, N; PETERS, C; LAKBIR, D. Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. British Journal of Cancer, 2011-09-27, roč. 105, čís. 7, s. 961–969. PMID: 21863026
PMCID: PMC3185943. Dostupné online [cit. 2018-01-14]. ISSN0007-0920. DOI: 10.1038/bjc.2011.327.
CHIOCCA, E. Antonio; RABKIN, Samuel D.. Oncolytic Viruses and Their Application to Cancer Immunotherapy. Cancer Immunology Research, 2014-04-01, roč. 2, čís. 4, s. 295–300. PMID: 24764576. Dostupné online [cit. 2018-01-14]. ISSN2326-6066. DOI: 10.1158/2326-6066.CIR-14-0015. (po anglicky)
FUKUHARA, Hiroshi; INO, Yasushi; TODO, Tomoki. Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer Science, 2016-10, roč. 107, čís. 10, s. 1373–1379. PMID: 27486853
PMCID: PMC5084676. Dostupné online [cit. 2018-01-14]. ISSN1347-9032. DOI: 10.1111/cas.13027.